The field of hematology is witnessing remarkable advancements, offering new hope for patients with rare blood disorders and cancers. In a recent discussion at the MOASC Annual Oncology Summit & Research Symposium, Dr. Aaron Goodman, MD, from UC San Diego, provided an in-depth look at Clarkson’s disease, relapsed diffuse large B-cell lymphoma (DLBCL), multiple myeloma, and low-risk myelodysplastic syndromes (MDS). This comprehensive session highlighted the latest treatment options, their challenges, and the importance of patient-centered care in navigating these complex conditions.
- Category
- Oncology

Be the first to comment